De Burlo Group Inc Eli Lilly & CO Transaction History

De Burlo Group Inc

$808 Million
Q3 2024

A detailed history of De Burlo Group Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, De Burlo Group Inc holds 40,801 shares of LLY stock, worth $29.8 Million. This represents 4.47% of its overall portfolio holdings.

Number of Shares

40,801

Previous 45,041 9.41%

Holding current value

$29.8 Million

Previous $40.8 Million 11.36%

% of portfolio

4.47%

Previous 5.56%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $3.27 Million - $4.07 Million	-4,240 Reduced 9.41%	40,801 $36.1 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $630,636 - $790,864	-870 Reduced 1.89%	45,041 $40.8 Million
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $4.45 Million - $5.95 Million	-7,513 Reduced 14.06%	45,911 $35.7 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $63,900 - $88,097	-147 Reduced 0.27%	53,424 $28.7 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $15.2 Million - $20.3 Million	43,391 Added 426.24%	53,571 $25.1 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $13.9 Million - $16.3 Million	-44,650 Reduced 81.43%	10,180 $3.5 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $3.62 Million - $4.22 Million	11,256 Added 25.83%	54,830 $20.1 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $12 Million - $13.7 Million	40,619 Added 1374.59%	43,574 $14.1 Million
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $972,488 - $1.14 Million	-3,489 Reduced 54.14%	2,955 $958,000
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $105,610 - $131,247	-450 Reduced 6.53%	6,444 $1.85 Million
Q2 2021 Aug 05, 2021	BUY	$180.55 - $233.54 $54,165 - $70,062	300 Added 4.55%	6,894 $1.58 Million
Q4 2020 Feb 05, 2021	BUY	$130.46 - $172.63 $662,736 - $876,960	5,080 Added 335.54%	6,594 $1.11 Million
Q3 2020 Nov 05, 2020	BUY	$146.22 - $169.13 $221,377 - $256,062	1,514 New	1,514 $224,000
Q1 2020 May 07, 2020	SELL	$119.05 - $147.35 $192,146 - $237,822	-1,614 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$106.92 - $132.43 $172,568 - $213,742	1,614 New	1,614 $212,000
Q2 2019 Aug 07, 2019	SELL	$110.79 - $129.32 $7.58 Million - $8.85 Million	-68,414 Closed	0 $0
Q1 2019 May 09, 2019	SELL	$111.31 - $131.02 $4.94 Million - $5.82 Million	-44,400 Reduced 39.36%	68,414 $8.88 Million
Q4 2018 Feb 07, 2019	BUY	$105.9 - $118.64 $3.7 Million - $4.14 Million	34,900 Added 44.79%	112,814 $13.1 Million
Q3 2018 Nov 08, 2018	BUY	$85.86 - $107.31 $6.69 Million - $8.36 Million	77,914 New	77,914 $8.36 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $693B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of De Burlo Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on De Burlo Group Inc with notifications on news.

Account

De Burlo Group Inc Eli Lilly & CO Transaction History